Life | Free Full-Text | The Impact of Nonalcoholic Fatty Liver Disease on Severe Community-Acquired Pneumonia Outcomes
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates - ScienceDirect
IJMS | Free Full-Text | Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease
FibroScan® Fat Results - Tawazun Health
A, Change in controlled attenuation parameter (CAP) after treatment... | Download Scientific Diagram
Frontiers | Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
Cureus | Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease | Article
Prevalence of increased CAP (CAP > 248 dB/m) and increased liver... | Download Scientific Diagram
Noninvasive tests for nonalcoholic fatty liver disease in a multi‐ethnic population: The HELIUS study - Dijk - Hepatology Communications - Wiley Online Library
Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study | PLOS ONE
Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease
Nutrients | Free Full-Text | Overview of Non-Alcoholic Fatty Liver Disease ( NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development
A simple blood test to identify patients at risk of nonalcoholic fatty liver disease - ResOU
Comparison of controlled attenuation parameter (CAP) values in patients... | Download Scientific Diagram
Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of liver steatosis using the Controlled Attenuation Parameter (CAP) as the reference method. | Semantic Scholar
Cells | Free Full-Text | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment
Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD | Nature Reviews Gastroenterology & Hepatology
IJMS | Free Full-Text | Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
The Specialists
Screening for non‐alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter‐transient elastography - Teeratorn - 2020 - JGH Open - Wiley Online Library
Biomedicines | Free Full-Text | Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies - The Lancet Diabetes & Endocrinology
